What is Five Star Diagnostics?
Five Star Diagnostics, LLC operates as a specialized mobile diagnostic service provider, dedicated to enhancing patient outcomes for individuals with diabetes. The company leverages innovative medical devices and specialty services, including telemedicine-powered diabetic retinopathy exams. By facilitating the secure transmission of retinal images and diagnostic reports to healthcare providers, Five Star Diagnostics aims to bridge the accessibility gap for crucial eye care. Their client base encompasses health plans, health systems, physicians, and patients, reflecting a broad market reach and a commitment to fostering long-term partnerships built on exceptional service.
How much funding has Five Star Diagnostics raised?
Five Star Diagnostics has raised a total of $31K across 1 funding round:
Debt
$31K
Debt (2021): $31K with participation from PPP
What's next for Five Star Diagnostics?
Positioned at a significant Series B/C stage, Five Star Diagnostics' recent substantial expansion capital suggests a strategic focus on scaling its operations and potentially broadening its service offerings. The company's emphasis on addressing preventable blindness through enhanced access to eye exams aligns with growing healthcare demands for efficient and patient-centric solutions. Future developments are likely to involve expanding their mobile diagnostic fleet, enhancing their telemedicine platform, and forging deeper integrations with healthcare systems and payers to further penetrate the market and solidify their role in diabetic patient care.
See full Five Star Diagnostics company page
